Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac101Source: DataRank Database

Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia is a research paper published in JNCI Journal of the National Cancer Institute (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 4.65)OA: greenTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Maoxiang Qian ORCID,Charnise Goodings ORCID,Yang Zhang ORCID,Wenjian Yang ORCID,Ping Wang ORCID

Live enrichment

PubMed:35575404 OpenAlex:https://openalex.org/W4280629034

National Institutes of Health

Grant: GM115279

National Institutes of Health

Grant: CA234490

National Institutes of Health

Grant: CA176063

National Institutes of Health

Grant: CA114766

Medical Research Council

Grant: MC_PC_17228

Medical Research Council

Grant: MC_QA137853

NCI NIH HHS

Grant: R01 CA234490

NCI NIH HHS

Grant: U24 CA114766

NCI NIH HHS

Grant: U01 CA176063

NIGMS NIH HHS

Grant: P50 GM115279

FWCI

4.65

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

greenLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9468286

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/9468286

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9468286

publisherhttps://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djac101/44249856/djac101.pdf

publisherhttps://academic.oup.com/jnci/article-pdf/114/9/1287/45751647/djac101.pdf

Fields of Study

Acute Lymphoblastic Leukemia researchChromatin Remodeling and CancerAcute Myeloid Leukemia ResearchMedicineBiologyChildDNA-Binding ProteinsGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single NucleotidePrecursor Cell Lymphoblastic Leukemia-LymphomaTranscription Factors

MeSH Terms

ChildDNA-Binding ProteinsHumansTranscription FactorsGenetic Predisposition to DiseasePolymorphism, Single NucleotidePrecursor Cell Lymphoblastic Leukemia-LymphomaGenome-Wide Association Study

Keywords

EnhancerBiologyTranscription factorChromatin immunoprecipitationGeneMolecular biologyGeneticsCancer researchGene expressionPromoter

Sustainable Development Goals

SDG 0: Good health and well-being